Cargando…

Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy

SIMPLE SUMMARY: The aim of this review is to detailed immunological effects of chemotherapies focusing on 2 main effects: immunogenic cell death and depletion of suppressive cells. It provides a strong rational for combination of chemotherapy and immunotherapy. ABSTRACT: Chemotherapy is initially us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fumet, Jean-David, Limagne, Emeric, Thibaudin, Marion, Ghiringhelli, Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565832/ https://www.ncbi.nlm.nih.gov/pubmed/32947882 http://dx.doi.org/10.3390/cancers12092637

Ejemplares similares

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment
por: Fumet, Jean-David, et al.
Publicado: (2020)

Immunological features of coronavirus disease 2019 in patients with cancer
por: Thibaudin, Marion, et al.
Publicado: (2020)

Protocol for simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry
por: Daumoine, Susy, et al.
Publicado: (2023)

Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
por: Limagne, Emeric, et al.
Publicado: (2019)

Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness
por: Barnestein, Robby, et al.
Publicado: (2022)

Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer
por: Klopfenstein, Quentin, et al.
Publicado: (2021)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
por: Grapin, Mathieu, et al.
Publicado: (2019)

Double-edged sword.
Publicado: (1994)

Granulomatosis with polyangitis with mononeuritis multiplex-immunosuppressives playing a double-edged sword
por: Mukherjee, Subhasis, et al.
Publicado: (2014)

Cell death and infection: A double-edged sword for host and pathogen survival
por: Ashida, Hiroshi, et al.
Publicado: (2011)

Salicylic Acid: A Double-Edged Sword for Programed Cell Death in Plants
por: Radojičić, Ana, et al.
Publicado: (2018)

Host cell death during infection with Chlamydia: a double-edged sword
por: Sixt, Barbara S
Publicado: (2020)

The double-edged sword of evolution
por: Kruzel-Davila, Etty, et al.
Publicado: (2017)

A double-edged sword
por: Vandebotermet, Martijn, et al.
Publicado: (2020)

γδ T cells in malaria: a double‐edged sword
por: Pamplona, Ana, et al.
Publicado: (2020)

Phase III elimination: another two-edge sword.
por: Vore, M
Publicado: (1994)

Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy
por: Gabani, Mohanad, et al.
Publicado: (2021)

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers
por: Medjebar, Soleine, et al.
Publicado: (2020)

Diet in Intestinal Fibrosis: A Double-Edged Sword
por: Marion-Letellier, Rachel, et al.
Publicado: (2021)

Seatbelt: A Double-Edged Sword
por: Raychaudhuri, P., et al.
Publicado: (2012)

The double-edged sword of fibronectin in atherosclerosis
por: Moore, Kathryn J, et al.
Publicado: (2012)

ATT- A Double Edged Sword?
por: Gude, D., et al.
Publicado: (2011)

Leukocytes: The Double-Edged Sword in Fibrosis
por: Kryczka, Jakub, et al.
Publicado: (2015)

Apoptosis, A Double-Edge Sword!
por: Rossello, Xavier, et al.
Publicado: (2017)

Doubled-Edged Swords in the Biology of Conflict
por: Sapolsky, Robert M.
Publicado: (2018)

Immunity to PRRSV: Double-edged sword
por: Molitor, T.W., et al.
Publicado: (1997)

Warfarin: A double-edged sword
por: Yadav, Prabhakar, et al.
Publicado: (2019)

MAVS is a double-edged sword
por: Huang, Christina, et al.
Publicado: (2023)

Interactions of Viruses with Dendritic Cells: A Double-edged Sword
por: Bhardwaj, Nina
Publicado: (1997)

Dendritic cells a double-edge sword in autoimmune responses
por: Amodio, Giada, et al.
Publicado: (2012)

Sertoli Cell Immune Regulation: A Double-Edged Sword
por: Washburn, Rachel L., et al.
Publicado: (2022)

Double-edged sword: γδ T cells in mucosal homeostasis and disease
por: Kang, In, et al.
Publicado: (2023)

At War Within: The Double-Edged Sword of Immunity
por: Edgar, D
Publicado: (1997)

Inflammasomes in cancer: a double-edged sword
por: Kolb, Ryan, et al.
Publicado: (2014)

Financial Incentives to Reviewers: Double-edged Sword
por: Garg, Pankaj Kumar
Publicado: (2015)

ATP, a double-edged sword in cancer
por: Jiang, Jean X., et al.
Publicado: (2015)

Reply: Apoptosis, A Double-Edge Sword!
por: Weil, Brian R., et al.
Publicado: (2017)

Autophagy, a double-edged sword in hepatocarcinogenesis
por: Tian, Yongjun, et al.
Publicado: (2015)

Platelets in aging and cancer—“double-edged sword”
por: Faria, Alessandra V. S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ojn85cf0ibrooflevrldev44tb